Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids

Abstract Background Patient-derived organoids (PDOs) represent a promising approach for replicating the characteristics of original tumors and facilitating drug testing for personalized treatments across diverse cancer types. However, clinical evidence regarding their application to esophageal cance...

Full description

Bibliographic Details
Published in:Journal of Translational Medicine
Main Authors: Suya Shen, Bing Liu, Wenyan Guan, Ziyao Liu, Yuqing Han, Yingzhe Hu, Yiqiang Chen, Siyuan Liu, Jian He, Zhiwen Li, Weifeng Tang, Pengju Zhang, Wei Ren, Yudong Qiu, Hongping Zheng, Jingjing Li
Format: Article
Language:English
Published: BMC 2024-12-01
Subjects:
Esophageal squamous cell carcinoma
Organoids
Chemotherapy
Precision medicine
Online Access:https://doi.org/10.1186/s12967-024-05967-1

Internet

https://doi.org/10.1186/s12967-024-05967-1

Similar Items